Financial Backing

Mobio Interactive’s digital therapeutic platform “Dawn DTx” has CE MDR Class 1, DCB 0129 ,and ISO 27001-2022 certification; and is GDPR-, HIPAA- and PHIPA-compliant.

Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, Dawn DTx, Mobio has published over 20 peer-reviewed papers to date from over a dozen completed clinical studies.